Repost:
Real numbers --- Nivida trades at 9x sales and it is growing sales at like 20%/year. Sona is much smaller and is growing sales at 100%/year.
Even if we were to trade at NVDA's multiple we would be at a 9x15M (sales) which is 135M Market cap, or about 5.5x higher than where we are here, which is roughly 77 cents.
Of course, most investors would give Sona a far higher multiple because of its small size and fast sales growth pace. No reason this wouldnt trade at 15-20x sales which of course would be 1.50+.
Of note, this is the OTC and there are about 7 of us here that are retailers, the rest are insiders that buy and hold and not few others know about this, so this wont trade at a normal valuation until this moves to a higher exchange IMO and/or gets some legit big money accredited investors involved.
We are currently trading at 1.8x sales.